-
1
Oncolytic Virotherapy for Hematological Malignancies
Published 2012-01-01“…Hematological malignancies such as leukemias, lymphomas, multiple myeloma (MM), and the myelodysplastic syndromes (MDSs) primarily affect adults and are difficult to treat. …”
Get full text
Article -
2
Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy
Published 2018-01-01Get full text
Article -
3
GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE
Published 2023-04-01“… Advances in molecular biology and genetic testing have greatly improved our understanding of the genetic basis of hematologic malignancies and have enabled the identification of new cancer predisposition syndromes. …”
Get full text
Article -
4
Clinical advances in antibody-drug conjugates for hematological malignancies
Published 2024-12-01“…Globally, there are over a hundred ADCs in development, and it is hoped that more breakthroughs will be achieved in the future to further optimize the treatment strategies for hematologic malignancies.…”
Get full text
Article -
5
CAR-T Therapy Beyond B-Cell Hematological Malignancies
Published 2025-01-01“…Despite the advances of CAR-T cells in certain hematological malignancies, mostly from B-cell derivations such as non-Hodgkin lymphomas, acute lymphoblastic leukemia and multiple myeloma, a significant portion of other hematological and non-hematological pathologies can benefit from this innovative treatment, as the results of clinical studies are demonstrating. …”
Get full text
Article -
6
Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies
Published 2025-01-01Subjects: Get full text
Article -
7
Ulcerative Colitis in Hematological Malignancies: Paraneoplastic Manifestation or Coincidental Bystander?
Published 2020-01-01“…Evidence of coexistence of diverse hematological malignancies—lymphoma, leukemia, multiple myeloma, and myelodysplastic syndromes—and either ulcerative colitis or Crohn’s disease can be found in the literature. …”
Get full text
Article -
8
Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies
Published 2016-01-01Get full text
Article -
9
Frequency and Treatment Outcome of Invasive Fungal Infections in Children with Hematological Malignancies
Published 2025-01-01“…Conclusion: The frequency of IFS was 17.1% among children with hematological malignancies. Mortality was relatively high (24.4%) among children with IFIs which warrants early identification and treatment of IFIs among children with hematological malignancies. …”
Get full text
Article -
10
Extracellular NM23 Protein as a Therapeutic Target for Hematologic Malignancies
Published 2012-01-01“…An elevated serum level of NM23-H1 protein is a poor prognostic factor in patients with various hematologic malignancies. The extracellular NM23-H1 protein promotes the in vitro growth and survival of acute myelogenous leukemia (AML) cells and inversely inhibits the in vitro survival of normal peripheral blood monocytes in primary culture at concentrations equivalent to the levels found in the serum of AML patients. …”
Get full text
Article -
11
Multimodality imaging of hematologic malignancies affecting the breast: a pictorial essay
Published 2024-10-01“…Hematologic malignancies affecting the breast are a heterogeneous group that includes lymphomas, leukemias, and multiple myeloma. …”
Get full text
Article -
12
Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies
Published 2008-01-01“…Infiltrative lung disease is a well-known complication of antineoplastic agents in patients with hematological malignancies. Novel agents are constantly being added to available treatments. …”
Get full text
Article -
13
Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy
Published 2014-01-01“…INTRODUCTION: Voriconazole plasma concentrations have been correlated with oral dosing in healthy subjects, but have been poorly characterized in ill patients with hematological malignancies receiving intensive chemotherapy.…”
Get full text
Article -
14
BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies
Published 2025-01-01Get full text
Article -
15
ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives
Published 2019-01-01“…Paraneoplastic AAV seems to be an uncommon presentation of hemopathies. Hematologic malignancy risk in AAV is more likely to be increased by cyclophosphamide, although not yet definitely proven. …”
Get full text
Article -
16
Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes
Published 2010-01-01“…This paper has two objectives: first to highlight the potential uses for PPARγ agonists in anticancer therapy with special emphasis on their role when used as adjuvant or combined therapy in the treatment of hematological malignancies found in the vasculature, marrow, and eyes, and second, to review the potential role PPARγ and/or its ligands may have in modulating cancer-associated angiogenesis and tumor-stromal microenvironment crosstalk in bone marrow.…”
Get full text
Article -
17
-
18
Clinical Characteristics and Optimization of Empirical Antimicrobial Therapy for Febrile Neutropenia in Patients With Hematologic Malignancies
Published 2025-02-01Subjects: “…hematological malignancy…”
Get full text
Article -
19
Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity
Published 2025-02-01Subjects: Get full text
Article -
20
